Helicobacter pylori
|
Disruption of stomach and colonic epithelial integrity creates a niche in stomach suitable for further pathogenic bacterial invasion [40]. |
Stomach and colorectal. |
Fusobacterium nucleatum
|
Suspension of disintegration of β-catenin signalling, increased expression of TLR4 activation of p21- activated kinase and cyclin D1 [41], increased inflammatory gene expression, and suppression of antitumour NKT cells via effector molecules FadA and Fap2 [42,43]. |
Stomach, colorectal, oral, and lung. |
Bacteroides fragilis
|
Reactive-oxygen-species (ROS) generation leading to DNA damage, colon-epithelial-barrier disruption, and depletion of mucous membrane, causing increased inflammation [44,45,46]. |
Stomach, colorectal, and lung. |
Pathogenic Escherichia coli
|
Toxin colibactin indirectly induces release of growth factors in tumour microenvironment; cytotoxic necrotizing factor (CNF)-mediated disruption of host cell DNA repair mechanism [47,48]. |
Stomach and lung. |
Salmonella sp. |
Stabilises and prevents degradation of β-catenin by deubiquitinase activity of its AvrA protein [49,50,51]. |
Stomach, colorectal, gall-bladder, and lung. |
Peptostreptococcus anaerobius
|
Increases expression of SREB2 gene via ROS, causing increased cholesterol biosynthesis in colon [52]. |
Colorectal. |
Citrobacter rodentium
|
Loss of cell polarity, depletion of epithelial barrier, and increased inflammation [53]. |
Colorectal. |
Mycobacterium tuberculosis, Streptococcus viridans, Haemophilus influenza, Streptococcus pnuemoniae, Staphyloccocus
|
Involved in various chronic inflammatory lung disorders like asthma, cystic fibrosis, and chronic obstructive pulmonary disease; potential for accelerating tumourigenesis via inflammatory cytokines like tumour necrosis factor [54,55,56]. |
Lung. |
Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans
|
Reach pancreas from oral cavity through blood circulation and act as secondary drivers of cancer; impair host innate immunity, leading to increased colonisation by other bacteria, leading to chronic inflammation of pancreas causing accelerated tumourigenesis [57,58,59]. |
Pancreatic. |
Proteobacteria, Betaproteobacteria, Firmicutes, Alcaligenaceae, Burkholderiales |
Alter metabolism and oestrogen recycling, and exert pressure on immune system [38]. |
Breast. |
P. gingivalis and Tannerella forsythia
|
Cause overexpression of inflammatory cytokines; gingipain K produced by P. gingivalis paralyses immune cells, and induce indirect overexpression of glucose-transporter (GLUT-1 and GLUT-4) genes that help in faster tumour-cell proliferation [60,61,62,63]. |
Oesophageal. |